Hypertension
Baduanjin, an ancient Chinese mind-body exercise, lowered blood pressure in a randomized trial
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
Adults with stage 1 hypertension who practiced baduanjin—an eight-movement Chinese mind-body routine—had modest but measurable reductions in systolic blood pressure over three months that were maintained at one year, with results comparable to brisk walking, according to a randomized trial published in the Journal of the American College of Cardiology.
A major review of global studies has found that higher consumption of legumes and soy foods is associated with a reduced risk of developing high blood pressure. People eating the most legumes were 16 percent less likely to develop hypertension, while high soy intake lowered risk by 19 percent.
Ti AI ṣe iroyin
Colombia's National Health Superintendence reported over 87,000 complaints from users with arterial hypertension between November 2025 and April 2026. The grievances focused on barriers to medications, appointments and treatments. Antioquia, Bogotá and Valle del Cauca accounted for the highest numbers.
Researchers at the University of Southern California have developed the first noninvasive method to capture the rhythmic pulsing of the brain's tiniest blood vessels. Using advanced 7T MRI, they found these pulses strengthen with age and hypertension, potentially disrupting waste clearance and contributing to Alzheimer's disease. The findings, published in Nature Cardiovascular Research, could lead to new biomarkers for neurodegenerative conditions.
Ti AI ṣe iroyin
A new study revealed that Baxdrostat significantly reduces blood pressure in patients with resistant hypertension. The findings challenge existing treatments and suggest a new option for managing this condition. Results were highlighted as part of recent medical advancements.